Metal ions, Alzheimer's disease and chelation therapy
Identifieur interne : 000064 ( Main/Exploration ); précédent : 000063; suivant : 000065Metal ions, Alzheimer's disease and chelation therapy
Auteurs : Ana Budimir [Croatie]Source :
- Acta Pharmaceutica [ 1330-0075 ] ; 2011-03-01.
English descriptors
Abstract
In the last few years, various studies have been providing evidence that metal ions are critically involved in the pathogenesis of major neurological diseases (Alzheimer, Parkinson). Metal ion chelators have been suggested as potential therapies for diseases involving metal ion imbalance. Neurodegeneration is an excellent target for exploiting the metal chelator approach to therapeutics. In contrast to the direct chelation approach in metal ion overload disorders, in neurodegeneration the goal seems to be a better and subtle modulation of metal ion homeostasis, aimed at restoring ionic balance. Thus, moderate chelators able to coordinate deleterious metals without disturbing metal homeostasis are needed. To date, several chelating agents have been investigated for their potential to treat neurodegeneration, and a series of 8-hydroxyquinoline analogues showed the greatest potential for the treatment of neurodegenerative diseases.
Url:
DOI: 10.2478/v10007-011-0006-6
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metal ions, Alzheimer's disease and chelation therapy</title><author wicri:is="90%"><name sortKey="Budimir, Ana" sort="Budimir, Ana" uniqKey="Budimir A" first="Ana" last="Budimir">Ana Budimir</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4C02DB8310C7E2C698C17FB8C2CDFFEF93DDC89C</idno><date when="2011-03-15" year="2011">2011-03-15</date><idno type="doi">10.2478/v10007-011-0006-6</idno><idno type="url">https://api.istex.fr/document/4C02DB8310C7E2C698C17FB8C2CDFFEF93DDC89C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002115</idno><idno type="wicri:Area/Main/Curation">001E11</idno><idno type="wicri:Area/Main/Exploration">000064</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Metal ions, Alzheimer's disease and chelation therapy</title><author wicri:is="90%"><name sortKey="Budimir, Ana" sort="Budimir, Ana" uniqKey="Budimir A" first="Ana" last="Budimir">Ana Budimir</name><affiliation wicri:level="1"><country xml:lang="fr">Croatie</country><wicri:regionArea>Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb</wicri:regionArea><wicri:noRegion>10000 Zagreb</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Pharmaceutica</title><idno type="ISSN">1330-0075</idno><idno type="eISSN">1846-9558</idno><imprint><publisher>Versita</publisher><date type="published" when="2011-03-01">2011-03-01</date><biblScope unit="volume">61</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="14">14</biblScope></imprint><idno type="ISSN">1330-0075</idno></series><idno type="istex">4C02DB8310C7E2C698C17FB8C2CDFFEF93DDC89C</idno><idno type="DOI">10.2478/v10007-011-0006-6</idno><idno type="ArticleID">v10007-011-0006-6</idno><idno type="Related-article-Href">v10007-011-0006-6.pdf</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1330-0075</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer's disease</term><term>chelation therapy</term><term>metal chelators</term><term>metal ions</term><term>neurodegeneration</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the last few years, various studies have been providing evidence that metal ions are critically involved in the pathogenesis of major neurological diseases (Alzheimer, Parkinson). Metal ion chelators have been suggested as potential therapies for diseases involving metal ion imbalance. Neurodegeneration is an excellent target for exploiting the metal chelator approach to therapeutics. In contrast to the direct chelation approach in metal ion overload disorders, in neurodegeneration the goal seems to be a better and subtle modulation of metal ion homeostasis, aimed at restoring ionic balance. Thus, moderate chelators able to coordinate deleterious metals without disturbing metal homeostasis are needed. To date, several chelating agents have been investigated for their potential to treat neurodegeneration, and a series of 8-hydroxyquinoline analogues showed the greatest potential for the treatment of neurodegenerative diseases.</div></front></TEI><affiliations><list><country><li>Croatie</li></country></list><tree><country name="Croatie"><noRegion><name sortKey="Budimir, Ana" sort="Budimir, Ana" uniqKey="Budimir A" first="Ana" last="Budimir">Ana Budimir</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000064 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000064 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4C02DB8310C7E2C698C17FB8C2CDFFEF93DDC89C
|texte= Metal ions, Alzheimer's disease and chelation therapy
}}
| This area was generated with Dilib version V0.6.23. |  |